Early Use of Drug Might Slow Progression of Multiple Sclerosis

Early use of the multiple sclerosis drug interferon beta-1a might slow and even stop progression of the disease, according to new research from the American Academy of Neurology. Patients who received interferon soon after their first disease symptoms were less likely to see the disease progress into "clinically definite" multiple sclerosis, which is categorized as having had two separate attacks along with two separate lesions. Multiple sclerosis is an autoimmune disease that affects the...Full Story
Commenting on this article is closed.